VENTRINOVA
VentriNova is a regenerative medicine company focused on reversing cardiac damage by activation of intrinsic repair pathways to generate de novo heart muscle cells. VentriNovaโs first generation product is a gene therapy that delivers a critical mitotic regulator to diseased heart tissue to stimulate proliferation of cardiac muscle cells.
VENTRINOVA
Industry:
Clinical Trials Genetics Therapeutics
Founded:
2006-01-01
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.ventrinovainc.com
Total Employee:
1+
Status:
Active
Contact:
508-362-3087
Total Funding:
1000 K USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Google Font API WordPress LetsEncrypt Font Awesome Mobile Non Scaleable Content IPv6 Cloudflare Hosting Wordpress Plugins
Similar Organizations
Chaperone Therapeutics
Chaperone Therapeutics is developing frontline therapies to address diseases of protein misfolding
Lannett Company
Lannett develops, manufactures, and distributes generic prescription pharmaceutical products in tablet.
Recensa Therapeutics
Recensa Therapeutics, Inc. has a new approach to treating psoriasis: targeting oxidative stress.
Current Advisors List
Investors List
Broadview Ventures
Broadview Ventures investment in Seed Round - Ventrinova
Official Site Inspections
http://www.ventrinovainc.com
- Host name: 172.67.159.240
- IP address: 172.67.159.240
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Ventrinova"
Ventrinova - Crunchbase Company Profile & Funding
VentriNova is a regenerative medicine company focused on reversing cardiac damage by activation of intrinsic repair pathways to generate de novo heart muscle cells.See details»
VentriNova 2025 Company Profile: Valuation, Funding & Investors
Information on valuation, funding, cap tables, investors, and executives for VentriNova. Use the PitchBook Platform to explore the full profile.See details»
Centre de médecine régénérative
STRATÉGIE TRANSLATIONNELLE. L'administration par cathéter cardiaque dans le cลur infarci où les particules virales se diffusent rapidement dans le tissu myocardique et stimulent la division des cardiomyocytes sains matures dans โฆSee details»
VentriNova Company Profile | Management and Employees List
Www.ventrinovainc.com . VentriNova Profile and History. VentriNova is a preclinical stage cardiac regenerative gene therapy company focused on reversing cardiac damage by activation of โฆSee details»
VentriNova - VentureRadar
Dansk Biotek Unknown n/a DANISH BIOTECH is a trade organization for Danish biotech companies with the aim to promote opportunities for biotechnology research, development and โฆSee details»
VentriNova Inc - Company Profile and News - Bloomberg Markets
Company profile page for VentriNova Inc including stock price, company news, executives, board members, and contact informationSee details»
VentriNova - Overview, News & Similar companies | ZoomInfo.com
View VentriNova (www.ventrinovainc.com) location in New York, United States , revenue, industry and description. Find related and similar companies as well as employees by title and much โฆSee details»
Ventrinova: Contact Details and Business Profile - RocketReach
VentriNova is a preclinical stage cardiac regenerative gene therapy company focused on reversing cardiac damage by activation of intrinsic repair pathways to generate de novo heart โฆSee details»
VentriNova, Inc. | SBIR.gov
DESCRIPTION (provided by applicant): The morbidity and mortality due to cardiovascular disease is attributed to the lack of significant replicative potential of adult mammalian cardiomyocytes.See details»
VentriNova, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Explore VentriNova, Inc. with its drug pipeline, therapeutic area, technology platform, .See details»
VentriNova - Products, Competitors, Financials, Employees, โฆ
VentriNova is a cardiac regenerative gene therapy company focused on reversing cardiac damage by activation of intrinsic repair pathways to generate de novo heart muscle cells. Use โฆSee details»
VentriNova Inc | www.inknowvation.com
Business Identifier: Clinical treatments and gene therapy for the regeneration of heart tissueSee details»
Ventrinova - Tech Stack, Apps, Patents & Trademarks - Crunchbase
VentriNova is revolutionizing cardiac regenerative medicine by reversing cardiac damage pharmacologically.See details»
Ventrinova - Company Information, Competitors, News & FAQs
Find useful insights on Ventrinova's company details, tech stack, news alerts, competitors and more. Use 6sense to connect with top decision-makers at Ventrinova.See details»
VentriNova Company Profile | Industry Research and Analysis
Discover VentriNova, a trailblazer in advanced cardiovascular technologies. Specializing in innovative solutions for heart failure management, VentriNova provides cutting-edge devices โฆSee details»
Ventrinova Culture | Comparably
Learn about Ventrinova's culture, see what work's like, read reviews, and find job opportunities.See details»
VentriNova | CipherBio
Explore VentriNova's investment information, scientific platforms, therapeutic approaches, indications and more here!See details»
VentriNova's Gene Therapy Strategy Regenerates Heart Muscle โฆ
Feb 20, 2014 About VN-100 VN-100, the company's lead product, is a viral vector-based gene therapy that induces cardiomyocyte division in adult heart tissue by delivery of cyclin A2, a โฆSee details»
Research programme: CCNA2 gene therapy - VentriNova
25 Feb 2014 VentriNova is open to partnering opportunities for development of this research programme. www.ventrinovainc.com 19 Feb 2014 Preclinical trials in Myocardial infarction in โฆSee details»
GE Vernovaโs CEO on thriving through tariffs and supply chain โฆ
2 hours ago GE Vernova is now one year into life as an independent public company, much to celebrateโyour revenue rose to $35 billion. In 2024, GE Vernova was the yearโs fourth best โฆSee details»